← Open Payments lookup

MICHAEL STAMPER: Open Payments

NPI 1831318187 · THOMSON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$753 in 51 payments from 13 companies in 2025. Trend: 2023 $394 · 2024 $507 · 2025 $753

Food & beverage: $753
CompanyPaymentsAmount
ABBVIE INC.18$186
Novo Nordisk Inc12$147
Bayer Healthcare Pharmaceuticals Inc.4$92
Lilly USA, LLC4$71
Verona Pharma, Inc.2$47
PFIZER INC.2$40
UCB, Inc.1$33
Kowa Pharmaceuticals America, Inc.2$32
Collegium Pharmaceutical, Inc.2$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23

Products named: VRAYLAR, Ozempic, Kerendia, MOUNJARO, Ohtuvayre, PREVNAR 20, Briviact, ZORYVE.

Industry payments across GA — which companies pay providers there.